ImportRefusal LogoImportRefusal

PURE COMPOUNDING LAB INC

⚠️ Moderate Risk

FEI: 3013598301 • Burnaby, British Columbia • CANADA

FEI

FEI Number

3013598301

📍

Location

Burnaby, British Columbia

🇨🇦

Country

CANADA
🏢

Address

7635 North Fraser Way Suite #105A, , Burnaby, British Columbia, Canada

Moderate Risk

FDA Import Risk Assessment

39.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
4
Unique Violations
11/20/2019
Latest Refusal
12/7/2018
Earliest Refusal

Score Breakdown

Violation Severity
75.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
30.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
11/20/2019
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/21/2018
66VBN99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
27DRUG GMPS
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/7/2018
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is PURE COMPOUNDING LAB INC's FDA import refusal history?

PURE COMPOUNDING LAB INC (FEI: 3013598301) has 3 FDA import refusal record(s) in our database, spanning from 12/7/2018 to 11/20/2019.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. PURE COMPOUNDING LAB INC's FEI number is 3013598301.

What types of violations has PURE COMPOUNDING LAB INC received?

PURE COMPOUNDING LAB INC has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about PURE COMPOUNDING LAB INC come from?

All FDA import refusal data for PURE COMPOUNDING LAB INC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.